Publication:

Regulation of the androgen receptor by SET9-mediated methylation (2011)

Author(s): Gaughan L, Stockley J, Wang N, McCracken S, Truemann A, Armstrong K, Shaheen F, Watt K, McEwan I, Wang C, Pestell RG, Robson CN

    Abstract: The androgen receptor (AR) is a member of the nuclear hormone receptor family of transcription factors that plays a critical role in regulating expression of genes involved in prostate development and transformation. Upon hormone binding, the AR associates with numerous co-regulator proteins that regulate the activation status of target genes via flux to the post-translational modification status of histones and the receptor. Here we show that the AR interacts with and is directly methylated by the histone methyltransferase enzyme SET9. Methylation of the AR on lysine 632 is necessary for enhancing transcriptional activity of the receptor by facilitating both inter-domain communication between the N- and C-termini and recruitment to androgen-target genes. We also show that SET9 is pro-proliferative and anti-apoptotic in prostate cancer cells and demonstrates up-regulated nuclear expression in prostate cancer tissue. In all, our date indicate a new mechanism of AR regulation that may be therapeutically exploitable for prostate cancer treatment.

      • Date: 1 March 2011
      • Journal: Nucleic Acids Research
      • Volume: 39
      • Issue: 4
      • Pages: 1266-1279
      • Publisher: Oxford University Press
      • Publication type: Article
      • Bibliographic status: Published
      Staff

      Dr Luke Gaughan
      Senior Lecturer

      Professor Craig Robson
      Professor of Molecular Urology